What is ChengDu ShengNuo Biotec Co.,Ltd.'s (688117.SS) StockRank?

MoatMap's StockRank for ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) is 48/100, with a Hold signal. This is a composite score combining Quality (62), Value (28), and Momentum (49) factor ranks across MoatMap's 19,000+ stock universe.

Does ChengDu ShengNuo Biotec Co.,Ltd. have an economic moat?

ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is ChengDu ShengNuo Biotec Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is ChengDu ShengNuo Biotec Co.,Ltd. in?

ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688117.SS

HOLDAPPROVE

ChengDu ShengNuo Biotec Co.,Ltd. · Healthcare · China · $785M · Avg Vol: $13M/d

StockRank

P/E (TTM)

30.1x

ROE

16.9%

D/E

0.5x

Dividend %

1.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

The global explosion in demand for peptide-based therapeutics (specifically GLP-1 agonists for diabetes and obesity) has created an unprecedented capacity bottleneck. ChengDu ShengNuo Biotec is a highly specialized peptide CDMO with a strong quality score and a robust regulatory track record. As global pharma companies seek validated, high-utilization manufacturing partners to secure their supply chains, ShengNuo possesses immense pricing power and a long reinvestment runway, making it a classic Terry Smith quality compounder riding a powerful Druckenmiller macro wave.

COMPANY DESCRIPTION

ChengDu ShengNuo Biotec Co., Ltd. provides peptide drug CDMO services and manufactures peptide active pharmaceutical ingredients (APIs) and formulations. The company possesses specialized expertise in the large-scale synthesis of complex peptide drugs, serving both domestic and international pharmaceutical clients. It is a niche biotech CDMO with a strong regulatory track record and high technical barriers in solid-phase peptide synthesis.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	58M	64M	67M	110M	23.3%
EPS	0.06	0.07	0.05	0.15	34.1%
Shares	157M	157M	157M	157M	+0.4%
Debt	15M	39M	71M	79M	73.4%
Equity	122M	130M	136M	156M	8.6%
Op CF	14M	13M	4M	26M	23.1%
Inv CF	3M	-55M	-34M	-28M	—
Fin CF	6M	19M	28M	9M	—

PRICE (1M)-36.3%

SMA 50SMA 200

$3.46

RSI (14)

39.1

52W High

$4.99

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

15.6%86.2

ROE

16.9%85.5

GP/Assets

23.6%54.0

Op. Margin

34.7%95.0

FCF/Assets

-5.2%35.5

Piotroski

—55.8

Int. Cover

13.5x68.2

D/E Ratio

0.51x30.8

Current Ratio

2.12x39.2

Value

P/E (TTM)

30.1x36.7

EV/EBITDA

18.6x20.9

P/FCF

—N/A

P/B

4.7x25.4

P/S

6.6x33.5

Div Yield

1.1%28.9

Momentum

52W High %

69%56.0

RS 6M

-23%51.3

SMA 50/200

0.92x39.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

41%72.8

FUNDAMENTALS

Market Cap

$785M

P/E (Forward)

—

Gross Margin

56.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688117.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.(you)	$785M	48	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.	$672M	43	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.	$894M	40	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) — Stock Score Summary

ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) has a MoatMap StockRank of 48/100 based on Quality (62/100), Value (28/100), and Momentum (49/100) factor scores. The current signal is HOLD. The global explosion in demand for peptide-based therapeutics (specifically GLP-1 agonists for diabetes and obesity) has created an unprecedented capacity bottleneck. ChengDu ShengNuo Biotec is a highly specialized peptide CDMO with a strong quality score and a robust regulatory track record. As global pharma companies seek validated, high-utilization manufacturing partners to secure their supply chains, ShengNuo possesses immense pricing power and a long reinvestment runway, making it a classic Terry Smith quality compounder riding a powerful Druckenmiller macro wave.

Key Financial Metrics

Price	$3.46
Market Cap	$785M
P/E (TTM)	30.11
Price/Book	4.72
Return on Equity	16.9%
Return on Invested Capital	15.6%
Debt/Equity	51.25
Gross Margin	56.8%
Operating Margin	34.7%
Revenue Growth	32.5%
Dividend Yield	1.1%
Free Cash Flow	$-2M

ChengDu ShengNuo Biotec Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is ChengDu ShengNuo Biotec Co.,Ltd.’s (688117.SS) StockRank?: MoatMap’s StockRank for ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) is 48/100, with a Hold signal. It is a composite of Quality (62), Value (28), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does ChengDu ShengNuo Biotec Co.,Ltd. have an economic moat?: ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ChengDu ShengNuo Biotec Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ChengDu ShengNuo Biotec Co.,Ltd. in?: ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).